MGM PARTNERS CONSULTING
Click Here to Add a Title
Click Here to Add a Title
Small variations in a person’s genes can lead to significant adverse drug reactions, medication ineffectiveness and increased healthcare costs. Pharmacogenomic testing offers healthcare providers the needed tools to objectively choose the safest and most effective medication therapy for each patient.
Pharmacogenomics is the study of how genetic variations affect medication response. It allows healthcare providers to combine the latest genetic discoveries with pharmacology to determine if a patient has variations that may cause medications to process either too quickly or too slowly. Knowing this information ahead of time allows the provider to focus on medications that will lead to the most favorable outcomes
Who Might Benefit from Pharmacogenomic Testing?
Who Might Benefit from Pharmacogenomic Testing?
-Patients taking medications with genetic guidance on the package insert or listed on the “FDA Warning List”
-Patients with a personal or family history of a medication intolerance or side effects
-Treatment with a medication that has proven ineffective at the recommended dosing
-Treatment with multiple medications (polypharmacy)
-Patient who has recently undergone cardiac stent placement or has a planned procedure for possible stent placement
-Patient starting warfarin therapy
What is involved in Pharmacogenomic Testing?
What is involved in Pharmacogenomic Testing?
Pharmacogenomic testing is non-invasive and only requires a buccal swab sample. PGX testing is a one-time test that has a lifetime impact. Repeat testing is not needed unless additional genes that were not previously tested become clinically significant and commercially available.